HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EPA Initiates Comment Period For High-Volume Chemical Tests

This article was originally published in The Rose Sheet

Executive Summary

The Environmental Protection Agency is amending its high production volume chemical testing program with a 90-day review period to offer industry an opportunity to comment on toxicity test plans and summaries for chemicals before testing commences. The review period was announced at an EPA "stakeholders" meeting in Washington D.C. July 27.

The Environmental Protection Agency is amending its high production volume chemical testing program with a 90-day review period to offer industry an opportunity to comment on toxicity test plans and summaries for chemicals before testing commences. The review period was announced at an EPA "stakeholders" meeting in Washington D.C. July 27.

Under EPA's Chemical-Right-To-Know HPV Challenge Program, companies across a number of industries have been asked to sponsor safety testing on 2,800 chemicals produced or imported into the U.S. in quantities of more than 1 mil. pounds a year (1 (Also see "EPA Requests Manufacturers Conduct Safety Testing On HPV Chemicals" - HBW Insight, 25 Jan, 1999.)).

EPA has signed up sponsors for 1,153 chemicals to date, with 1,024 receiving full sponsorship. Cosmetic chemicals under review include oleic acid, stearic acid, methacrylic acid, toluene and ethyl alcohol. Procter & Gamble, Andrew Jergens, Dial and Henkel are among the participants from the personal care industry.

"The principle reasons for the 90-day review period are to provide opportunities for anyone having additional information on the chemical [or] additional existing data, to bring that forward [and] make it available to the study sponsors," Office of Pollution Prevention & Toxic Chemical Control Division Director Charlie Hour said. The comment period also will allow interested parties to voice concerns with chemical test plans to EPA, individual sponsors and the consortium.

The review period was proposed at previous EPA stakeholders meetings by industry, which expressed concern that the agency was not taking existing data into account, thus causing unnecessary animal tests to be conducted (2 (Also see "EPA High Production Chemicals Review Committee Suggested By P&G" - HBW Insight, 22 Mar, 1999.)). The final two stakeholders meetings will be held Sept. 21, hosted by the Chemical Manufacturers Association and in November, by the Doris Day Animal League.

The review period could produce a "bottle neck" effect of data if EPA does not promptly provide comments following the review period, CMA CHEMSTAR Panel Manager Kathleen Roberts said. Companies therefore should be permitted to move forward on research a few days following the comment period with or without a response from the agency, she maintained.

In response, Hour said EPA intends to review the comments quickly, although he acknowledged that initially, responses are likely to take a little longer.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS006963

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel